Intramuscular vs Intravenous SARS-CoV-2 Neutralizing Antibody Sotrovimab for Treatment of COVID-19 (COMET-TAIL): A Randomized Noninferiority Clinical Trial
Pharmacology, Toxicology and Pharmaceutical Science
2
14%
Agricultural and Biological Sciences
1
7%
Medicine and Dentistry
1
7%
Engineering
1
7%
Unknown
9
64%
Attention Score in Context
Attention Score in Context
This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 04 September 2023.
All research outputs
#21,846,187
of 32,749,057 outputs
Outputs from Open Forum Infectious Diseases
#4,558
of 6,531 outputs
Outputs of similar age
#205,545
of 387,837 outputs
Outputs of similar age from Open Forum Infectious Diseases
#128
of 160 outputs
Altmetric has tracked 32,749,057 research outputs across all sources so far. This one is in the 31st percentile – i.e., 31% of other outputs scored the same or lower than it.
So far Altmetric has tracked 6,531 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 19.3. This one is in the 27th percentile – i.e., 27% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 387,837 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 43rd percentile – i.e., 43% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 160 others from the same source and published within six weeks on either side of this one. This one is in the 16th percentile – i.e., 16% of its contemporaries scored the same or lower than it.